| 41. | In postmenopausal women, the selective estrogen receptor modulator raloxifene is occasionally administered instead of bisphosphonates.
|
| 42. | The first targeted therapies blocked the estrogen receptor molecule, inhibiting the growth of breast cancer.
|
| 43. | The coactivator of estrogen receptor induced BCAS3 gene expression.
|
| 44. | Tamoxifen works by blocking estrogen receptors in breast tissue.
|
| 45. | Again it was noted that AHN was not increase via activation of the estrogen receptors.
|
| 46. | LXA 4 binds to and activates estrogen receptor alpha.
|
| 47. | Estrogen fuels the growth of tumor cells in those cancers that have the estrogen receptors.
|
| 48. | Tumors whose cells carry estrogen receptors are more responsive to estrogen in a woman's body.
|
| 49. | Patients with estrogen receptor positive tumors will typically receive hormonal therapy after chemotherapy is completed.
|
| 50. | This may be due to estrogen receptor impacts.
|
